The Global Burden of RSV

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Susan Green developed a stubborn cough in December 2023. It has never gone away. Nearly two years after contracting respiratory syncytial virus, or RSV, Green, now aged 72, still suffers from…

Read More
Back To Top